Join us for this insightful webinar featuring Dr. Nitin Kapoor, who will address the widely discussed Semaglutide Price Crash. In this session, Dr. Kapoor will examine the reality behind recent conversations around semaglutide patent expiry and its implications for diabetes and obesity management. He will clarify common misconceptions, highlight the clinical significance of semaglutide, and discuss whether changing market dynamics truly translate into better patient access. Don’t miss this opportunity to gain evidence-based insights and separate facts from speculation!